Immune-mediated thrombocytopenia (IMT) causes dangerous platelet loss in dogs, requiring immunosuppressive treatment and careful monitoring to prevent life-threatening bleeding.
IMT causes genuine suffering - spontaneous bleeding from tiny hemorrhages is painful and frightening. The risk of fatal hemorrhage creates urgency in treatment. Immunosuppressive treatment carries its own welfare costs including infection susceptibility. Monitoring requires frequent blood tests, creating a clinical welfare burden that must be balanced against treatment benefit. Most dogs achieve remission with appropriate treatment, making early diagnosis and aggressive initial management the most welfare-positive approach.